Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer (Q34395619)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer |
scientific article |
Statements
1 reference
Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer (English)
1 reference
Joe J Stephenson
John Nemunaitis
Anil A Joy
Ying-Ming Jou
Da Zhang
Paul Statkevich
Siu-Long Yao
Yali Zhu
Honghong Zhou
Karen Small
Rajat Bannerji
Martin J Edelman
2 December 2013
1 reference